Detection of minimal residual disease in patients with multiple myeloma using clonotype-specific PCR primers designed from DNA extracted from archival bone marrow slides-Reference-Cited by-同舟云学术

Detection of minimal residual disease in patients with multiple myeloma using clonotype-specific PCR primers designed from DNA extracted from archival bone marrow slides

Published:2013-10 Issue:10 Volume:41 Page:894-902
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Takamatsu Hiroyuki,Ogawa Yoshiyasu,Kobayashi Noriko,Obata Kazue,Narisawa Tadashi,Nakayama Kouji,Munemoto Saori,Aoki Go,Ohata Kinya,Kumano Yoshihisa,Ozaki Jun,Murata Ryoichi,Kondo Yukio,Terasaki Yasushi,Kurokawa Toshiro,Miyamoto Toshihiro,Shimizu Naomi,Fukushima Toshihiro,Yoshida Akira,Ueda Takanori,Yoshida Takashi,Nakao Shinji

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference21 articles.

1. Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma;Ladetto;J Clin Oncol,2010

2. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation;Paiva;Blood,2008

3. Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response;Martinez-Sanchez;Br J Haematol,2008

4. Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry;Sarasquete;Haematologica,2005

5. Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma;Putkonen;Eur J Haematol,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Cell Dyscrasias;Tata Memorial Centre Textbook of Oncology;2024

2. Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan;eJHaem;2022-07-21

3. Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry;Annals of Hematology;2021-08-25

4. Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches;Frontiers in Oncology;2020-05-27

5. Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives;Frontiers in Oncology;2019-08-20